0 Comentários
0 Compartilhamentos
547 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Lung Transplant Therapeutics Market Growth and Future TrendsLung Transplant Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the Lung Transplant Therapeutics Market CAGR Value The global lung transplant therapeutics market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.8% in the...0 Comentários 0 Compartilhamentos 31 Visualizações 0 Anterior
-
Selective Estrogen Receptor Degraders (SERD) Therapeutics Market Analysis: Supply Chain, Pricing, and Forecast 2025 –2032Executive Summary Selective Estrogen Receptor Degraders (SERD) Therapeutics Market: Share, Size & Strategic Insights CAGR Value The global Selective Estrogen Receptor Degraders (SERD) therapeutics market size was valued at USD 4.80 billion in 2025 and is expected to reach USD 16.46 billion by 2033, at a CAGR of 16.66% during the forecast period The...0 Comentários 0 Compartilhamentos 256 Visualizações 0 Anterior
-
Selective Estrogen Receptor Degraders (SERD) Therapeutics Market Dynamics: Key Drivers and Restraints 2025 –2032Executive Summary Selective Estrogen Receptor Degraders (SERD) Therapeutics Market: Share, Size & Strategic Insights CAGR Value The global Selective Estrogen Receptor Degraders (SERD) therapeutics market size was valued at USD 4.80 billion in 2025 and is expected to reach USD 16.46 billion by 2033, at a CAGR of 16.66% during the forecast period The key...0 Comentários 0 Compartilhamentos 155 Visualizações 0 Anterior
-
Advanced Renal Cell Carcinoma Therapeutics Market: 7.3% CAGR Growth Through 2030According to a newly published market research report by 24LifeSciences, global advanced renal cell carcinoma therapeutics market was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 20242030. Advanced renal cell carcinoma therapeutics encompass targeted therapies,...0 Comentários 0 Compartilhamentos 152 Visualizações 0 Anterior
-
Advanced Renal Cell Carcinoma Therapeutics Market: 7.3% CAGR Growth Through 2030According to a newly published market research report by 24LifeSciences, global advanced renal cell carcinoma therapeutics market was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 20242030. Advanced renal cell carcinoma therapeutics encompass targeted therapies,...0 Comentários 0 Compartilhamentos 158 Visualizações 0 Anterior
-
Antisense and RNAi Therapeutics Market Size Projected to Reach USD 9.65 Billion by 2032“According to a new report published by Introspective Market Research, Antisense and RNAi Therapeutics Market by Product Type, Application, and End User, The Global Antisense and RNAi Therapeutics Market Size Was Valued at USD 4.4 Billion in 2023 and is Projected to Reach USD 9.65 Billion by 2032, Growing at a CAGR of 18.2% from 2024 to 2032.” The Antisense and RNAi Therapeutics...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
-
Bispecific T Cell Engager Therapeutics Market to Grow at 15.8% CAGR (2025–2032)According to a newly published market research report by 24LifeSciences, global bispecific T cell engager therapeutics market was valued at USD 5.8 billion in 2024 and is projected to reach USD 20.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 20252032. Bispecific T cell engagers (BiTEs) represent a revolutionary class of...0 Comentários 0 Compartilhamentos 174 Visualizações 0 Anterior
-
Bispecific T Cell Engager Therapeutics Market to Grow at 15.8% CAGR (2025–2032)According to a newly published market research report by 24LifeSciences, global bispecific T cell engager therapeutics market was valued at USD 5.8 billion in 2024 and is projected to reach USD 20.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 20252032. Bispecific T cell engagers (BiTEs) represent a revolutionary class of...0 Comentários 0 Compartilhamentos 196 Visualizações 0 Anterior
-
Bladder Cancer Therapeutics and Diagnostics Market Dynamics: North America Drivers, Restraints, Opportunities, and ChallengesThe global Bladder Cancer Therapeutics and Diagnostics Market by 2031 is witnessing steady expansion driven by rising bladder cancer incidence, rapid advancements in oncology innovation, and increasing adoption of precision-based healthcare solutions. A detailed Bladder Cancer Therapeutics and Diagnostics Market Dynamics analysis highlights that the market is being shaped by a combination of...0 Comentários 0 Compartilhamentos 330 Visualizações 0 Anterior
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Comentários 0 Compartilhamentos 970 Visualizações 0 Anterior
-
"Peptide and Oligonucleotide CDMO Market Forecast: What to Expect as it Expands by 12.5% CAGR"In addition to regulatory challenges, CDMOs are also addressing the sustainability concerns of the biopharmaceutical industry. Companies are seeking manufacturing solutions that reduce waste, improve energy efficiency, and use sustainable raw materials. As the industry continues to evolve, the ability of CDMOs to offer eco-friendly and sustainable manufacturing practices will be crucial in...0 Comentários 0 Compartilhamentos 5KB Visualizações 0 Anterior1
-
Albinism Drug Market 2031: Overview, Trends, Growth Factors and OpportunitiesThe Albinism Drug Market is gaining momentum as advancements in rare disease therapeutics and genetic research continue to reshape treatment approaches. Albinism, a hereditary condition affecting melanin production, requires comprehensive management strategies that include dermatological, ophthalmic, and supportive drug therapies. According to insights from The Insight Partners, the Albinism...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Anti-Radiation Drug Advancements Supporting Global Emergency ResponseThe market is benefiting from rising healthcare infrastructure investments across emerging economies. Improved access to advanced treatments is driving adoption. Growing medical preparedness frameworks support sustained expansion. The Anti-Radiation Drugs Market is expanding steadily as healthcare systems strengthen preparedness for radiation exposure risks across medical, industrial, and...0 Comentários 0 Compartilhamentos 6KB Visualizações 0 Anterior
-
Anti-Radiation Drugs Market Size, Share, and Strategic OutlookAdvancements in biotechnology are enabling the development of more targeted radioprotective treatments. These innovations improve cellular protection while minimizing adverse effects. The evolving therapeutic landscape supports sustained market progress. Future OutlookThe Anti-Radiation Drugs Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$...0 Comentários 0 Compartilhamentos 4KB Visualizações 0 Anterior
-
Biopharmaceutical Innovation Driving Glycosylated Peptide Market to US$ 2.56 BillionGlycosylated Peptide is a biologically modified peptide in which sugar moieties are attached to improve structural stability and functional performance. This modification enhances its pharmacokinetic properties and therapeutic effectiveness in various medical applications. Glycosylated peptides are widely explored in biotechnology for developing advanced and targeted drug therapies. The...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Comentários 0 Compartilhamentos 903 Visualizações 0 Anterior
Páginas impulsionada